+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cholera Vaccines Market by Vaccine Type (Injectable Vaccine, Oral Vaccine), Route Of Administration (Intramuscular, Oral), Dosage Form, Presentation Type, Distribution Channel, End User, Age Group, Application - Global Forecast 2025-2030- Product Image
Cholera Vaccines Market by Vaccine Type (Injectable Vaccine, Oral Vaccine), Route Of Administration (Intramuscular, Oral), Dosage Form, Presentation Type, Distribution Channel, End User, Age Group, Application - Global Forecast 2025-2030- Product Image
Sale

Cholera Vaccines Market by Vaccine Type (Injectable Vaccine, Oral Vaccine), Route Of Administration (Intramuscular, Oral), Dosage Form, Presentation Type, Distribution Channel, End User, Age Group, Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 188 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5968086
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Cholera Vaccines Market is undergoing significant transformation as evolving public health needs, global supply chain pressures, and technological progress shape new opportunities and challenges for stakeholders. Strategic agility, regulatory adaptability, and nuanced stakeholder collaboration are essential for sustained success in this environment.

Market Snapshot: Cholera Vaccines Market Growth and Development

The cholera vaccines market grew from USD 307.02 million in 2024 to USD 329.81 million in 2025. It is expected to continue its upward trajectory with a CAGR of 7.36%, reaching USD 470.18 million by 2030. This impressive growth is propelled by advances in immunization strategies, expanding vaccine deployment, and the prioritization of water sanitation interventions in regions where cholera is endemic or outbreak-prone.

Scope & Segmentation of the Cholera Vaccines Market

  • Vaccine Types: Includes both injectable and oral cholera vaccine offerings that address diverse immunological profiles and logistical needs.
  • Route of Administration: Intramuscular and oral pathways, supporting resource-driven deployment in various healthcare infrastructures.
  • Dosage Forms: Liquid and lyophilized forms, each with distinct storage and stability requirements.
  • Presentation Types: Multi-dose and single-dose presentations to support efficient outreach and minimize wastage.
  • Distribution Channels: Hospital pharmacy, online pharmacy, and retail pharmacy, providing multiple patient access points.
  • End Users: Ambulatory centers, clinics, hospitals, and research facilities, reflecting a broad spectrum of healthcare delivery environments.
  • Age Groups: Adult, geriatric, and pediatric populations, reflecting distinct immunization needs and safety profiles.
  • Applications: Prophylactic immunization and therapeutic interventions tailored to specific healthcare outcomes.
  • Geographical Coverage: Americas (including US, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (with regional diversity), and Asia-Pacific (with dynamic vaccine manufacturing and adoption growth).
  • Key Companies: Includes EuBiologics, Shantha Biotechnics, Incepta Vaccine, Sanofi Pasteur, Valneva SE, Emergent BioSolutions Inc., and Bharat Biotech International.

Key Takeaways for Senior Decision-Makers

  • Stakeholders are intensifying efforts to develop flexible vaccine platforms, enabling rapid response to both new outbreaks and evolving epidemiological patterns.
  • Strategic partnerships between private and public entities are facilitating risk sharing, pipeline innovation, and more robust delivery models.
  • Modernization of cold chain logistics and digital health integration are improving supply chain resilience and enhancing traceability from manufacturing through end-user administration.
  • Multilateral procurement initiatives and dynamic regulatory policies are influencing access, pricing, and market agility, particularly in response to trade and tariff changes.
  • Leading manufacturers are leveraging modular, scalable manufacturing to respond to both routine and emergency immunization demands more effectively.

Tariff Impact: Navigating US Tariff Policy Changes

Upcoming tariffs in the US on pharmaceutical components are prompting vaccine developers to reconsider sourcing strategies, production footprints, and supplier agreements. Companies are mitigating these impacts through hybrid manufacturing models and strategic engagement with trade associations. Long-term procurement contracts and stockpiling of critical materials are being adopted to safeguard against price volatility and maintain uninterrupted production schedules.

Methodology & Data Sources

Research findings are based on primary interviews with key sector executives, R&D and regulatory experts, and procurement specialists. Data triangulation integrates peer-reviewed literature, health agency reports, and validated industry benchmarks, cross-checked through consensus workshops. Expert review and scenario analysis further support the reliability of insights provided.

Why This Report Matters

  • Supports executives in making data-driven, strategic investment and operational decisions in a fast-evolving market.
  • Enables stakeholders to proactively manage risk, leverage supply chain innovation, and capitalize on emerging market opportunities.
  • Facilitates informed policy and partnership development that aligns innovation with public health and long-term sustainability goals.

Conclusion

The cholera vaccines market is marked by rapid advancements across technology, supply chain, and regulatory spheres. Decision-makers who integrate innovation, strategic partnerships, and robust policy engagement will be best positioned to drive impactful immunization outcomes globally.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of real-time epidemiological surveillance data to optimize cholera vaccine distribution in high-risk regions
5.2. Development of thermostable oral cholera vaccines to address cold chain logistics challenges in remote areas
5.3. Evaluation of single-dose oral cholera vaccine efficacy in emergency and outbreak response settings
5.4. Partnerships between public health agencies and vaccine manufacturers to accelerate affordable cholera vaccine access
5.5. Advancements in live attenuated cholera vaccine formulations aimed at enhancing mucosal immunity
5.6. Implementation of community engagement initiatives to boost cholera vaccination uptake rates in densely populated slums
5.7. Regulatory approval processes for next-generation cholera conjugate vaccines in endemic low-income countries
5.8. Impact of climate change and migration patterns on cholera outbreak frequency shaping vaccine deployment strategies
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cholera Vaccines Market, by Vaccine Type
8.1. Introduction
8.2. Injectable Vaccine
8.3. Oral Vaccine
9. Cholera Vaccines Market, by Route Of Administration
9.1. Introduction
9.2. Intramuscular
9.3. Oral
10. Cholera Vaccines Market, by Dosage Form
10.1. Introduction
10.2. Liquid
10.3. Lyophilized
11. Cholera Vaccines Market, by Presentation Type
11.1. Introduction
11.2. Multi Dose
11.3. Single Dose
12. Cholera Vaccines Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacy
12.3. Online Pharmacy
12.4. Retail Pharmacy
13. Cholera Vaccines Market, by End User
13.1. Introduction
13.2. Ambulatory Centers
13.3. Clinics
13.4. Hospitals
13.5. Research Facilities
14. Cholera Vaccines Market, by Age Group
14.1. Introduction
14.2. Adult
14.3. Geriatric
14.4. Pediatric
15. Cholera Vaccines Market, by Application
15.1. Introduction
15.2. Prophylactic
15.3. Therapeutic
16. Americas Cholera Vaccines Market
16.1. Introduction
16.2. United States
16.3. Canada
16.4. Mexico
16.5. Brazil
16.6. Argentina
17. Europe, Middle East & Africa Cholera Vaccines Market
17.1. Introduction
17.2. United Kingdom
17.3. Germany
17.4. France
17.5. Russia
17.6. Italy
17.7. Spain
17.8. United Arab Emirates
17.9. Saudi Arabia
17.10. South Africa
17.11. Denmark
17.12. Netherlands
17.13. Qatar
17.14. Finland
17.15. Sweden
17.16. Nigeria
17.17. Egypt
17.18. Turkey
17.19. Israel
17.20. Norway
17.21. Poland
17.22. Switzerland
18. Asia-Pacific Cholera Vaccines Market
18.1. Introduction
18.2. China
18.3. India
18.4. Japan
18.5. Australia
18.6. South Korea
18.7. Indonesia
18.8. Thailand
18.9. Philippines
18.10. Malaysia
18.11. Singapore
18.12. Vietnam
18.13. Taiwan
19. Competitive Landscape
19.1. Market Share Analysis, 2024
19.2. FPNV Positioning Matrix, 2024
19.3. Competitive Analysis
19.3.1. EuBiologics Co., Ltd.
19.3.2. Shantha Biotechnics Private Limited
19.3.3. Incepta Vaccine Ltd.
19.3.4. Sanofi Pasteur S.A.
19.3.5. Valneva SE
19.3.6. Emergent BioSolutions Inc.
19.3.7. Bharat Biotech International Limited
20. ResearchAI
21. ResearchStatistics
22. ResearchContacts
23. ResearchArticles
24. Appendix
List of Figures
FIGURE 1. CHOLERA VACCINES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CHOLERA VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CHOLERA VACCINES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CHOLERA VACCINES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CHOLERA VACCINES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 18. GLOBAL CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 20. GLOBAL CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. CHOLERA VACCINES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. CHOLERA VACCINES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 31. CHOLERA VACCINES MARKET: RESEARCHAI
FIGURE 32. CHOLERA VACCINES MARKET: RESEARCHSTATISTICS
FIGURE 33. CHOLERA VACCINES MARKET: RESEARCHCONTACTS
FIGURE 34. CHOLERA VACCINES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CHOLERA VACCINES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CHOLERA VACCINES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CHOLERA VACCINES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CHOLERA VACCINES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CHOLERA VACCINES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CHOLERA VACCINES MARKET SIZE, BY INJECTABLE VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CHOLERA VACCINES MARKET SIZE, BY INJECTABLE VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CHOLERA VACCINES MARKET SIZE, BY ORAL VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CHOLERA VACCINES MARKET SIZE, BY ORAL VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CHOLERA VACCINES MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CHOLERA VACCINES MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CHOLERA VACCINES MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CHOLERA VACCINES MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CHOLERA VACCINES MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CHOLERA VACCINES MARKET SIZE, BY LIQUID, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CHOLERA VACCINES MARKET SIZE, BY LYOPHILIZED, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CHOLERA VACCINES MARKET SIZE, BY LYOPHILIZED, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CHOLERA VACCINES MARKET SIZE, BY MULTI DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CHOLERA VACCINES MARKET SIZE, BY MULTI DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CHOLERA VACCINES MARKET SIZE, BY SINGLE DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CHOLERA VACCINES MARKET SIZE, BY SINGLE DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CHOLERA VACCINES MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CHOLERA VACCINES MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CHOLERA VACCINES MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CHOLERA VACCINES MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CHOLERA VACCINES MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CHOLERA VACCINES MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CHOLERA VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CHOLERA VACCINES MARKET SIZE, BY AMBULATORY CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CHOLERA VACCINES MARKET SIZE, BY AMBULATORY CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CHOLERA VACCINES MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CHOLERA VACCINES MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CHOLERA VACCINES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CHOLERA VACCINES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CHOLERA VACCINES MARKET SIZE, BY RESEARCH FACILITIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CHOLERA VACCINES MARKET SIZE, BY RESEARCH FACILITIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CHOLERA VACCINES MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CHOLERA VACCINES MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CHOLERA VACCINES MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CHOLERA VACCINES MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CHOLERA VACCINES MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CHOLERA VACCINES MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CHOLERA VACCINES MARKET SIZE, BY PROPHYLACTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CHOLERA VACCINES MARKET SIZE, BY PROPHYLACTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CHOLERA VACCINES MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CHOLERA VACCINES MARKET SIZE, BY THERAPEUTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS CHOLERA VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 101. CANADA CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 102. CANADA CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 103. CANADA CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 104. CANADA CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 105. CANADA CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 106. CANADA CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 107. CANADA CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2024 (USD MILLION)
TABLE 108. CANADA CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2025-2030 (USD MILLION)
TABLE 109. CANADA CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 110. CANADA CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 111. CANADA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. CANADA CHOLERA VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. CANADA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 114. CANADA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 115. CANADA CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 116. CANADA CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 117. MEXICO CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 118. MEXICO CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 119. MEXICO CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 120. MEXICO CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 121. MEXICO CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 122. MEXICO CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 123. MEXICO CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2024 (USD MILLION)
TABLE 124. MEXICO CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2025-2030 (USD MILLION)
TABLE 125. MEXICO CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 126. MEXICO CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 127. MEXICO CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. MEXICO CHOLERA VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. MEXICO CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 130. MEXICO CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 131. MEXICO CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 132. MEXICO CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL CHOLERA VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA CHOLERA VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 184. UNITED KINGDOM CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM CHOLERA VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 199. GERMANY CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 200. GERMANY CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 201. GERMANY CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 202. GERMANY CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 203. GERMANY CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 204. GERMANY CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 205. GERMANY CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2024 (USD MILLION)
TABLE 206. GERMANY CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2025-2030 (USD MILLION)
TABLE 207. GERMANY CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 208. GERMANY CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 209. GERMANY CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. GERMANY CHOLERA VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. GERMANY CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 212. GERMANY CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 213. GERMANY CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 214. GERMANY CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 215. FRANCE CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 216. FRANCE CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 217. FRANCE CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 218. FRANCE CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 219. FRANCE CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 220. FRANCE CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 221. FRANCE CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2024 (USD MILLION)
TABLE 222. FRANCE CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2025-2030 (USD MILLION)
TABLE 223. FRANCE CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 224. FRANCE CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 225. FRANCE CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. FRANCE CHOLERA VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. FRANCE CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 228. FRANCE CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 229. FRANCE CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 230. FRANCE CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 231. RUSSIA CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 232. RUSSIA CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 233. RUSSIA CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 234. RUSSIA CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 247. ITALY CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 248. ITALY CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 249. ITALY CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 250. ITALY CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 251. ITALY CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 252. ITALY CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 253. ITALY CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2024 (USD MILLION)
TABLE 254. ITALY CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2025-2030 (USD MILLION)
TABLE 255. ITALY CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 256. ITALY CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 257. ITALY CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. ITALY CHOLERA VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. ITALY CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 260. ITALY CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 261. ITALY CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 262. ITALY CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 263. SPAIN CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 264. SPAIN CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 265. SPAIN CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 266. SPAIN CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 267. SPAIN CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 268. SPAIN CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 269. SPAIN CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2024 (USD MILLION)
TABLE 270. SPAIN CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2025-2030 (USD MILLION)
TABLE 271. SPAIN CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 272. SPAIN CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 273. SPAIN CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. SPAIN CHOLERA VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. SPAIN CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 276. SPAIN CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 277. SPAIN CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 278. SPAIN CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES CHOLERA VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 295. SAUDI ARABIA CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 296. SAUDI ARABIA CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 298. SAUDI ARABIA CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 300. SAUDI ARABIA CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2024 (USD MILLION)
TABLE 302. SAUDI ARABIA CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2025-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 304. SAUDI ARABIA CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 306. SAUDI ARABIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 308. SAUDI ARABIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 310. SAUDI ARABIA CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 311. SOUTH AFRICA CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 312. SOUTH AFRICA CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 313. SOUTH AFRICA CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 314. SOUTH AFRICA CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 316. SOUTH AFRICA CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2024 (USD MILLION)
TABLE 318. SOUTH AFRICA CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2025-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 320. SOUTH AFRICA CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 322. SOUTH AFRICA CHOLERA VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 324. SOUTH AFRICA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 325. SOUTH AFRICA CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 326. SOUTH AFRICA CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 327. DENMARK CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 328. DENMARK CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 329. DENMARK CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 330. DENMARK CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 331. DENMARK CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 332. DENMARK CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 333. DENMARK CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2024 (USD MILLION)
TABLE 334. DENMARK CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2025-2030 (USD MILLION)
TABLE 335. DENMARK CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 336. DENMARK CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 337. DENMARK CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 338. DENMARK CHOLERA VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 339. DENMARK CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 340. DENMARK CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 341. DENMARK CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 342. DENMARK CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 343. NETHERLANDS CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 344. NETHERLANDS CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 345. NETHERLANDS CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 346. NETHERLANDS CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 347. NETHERLANDS CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-202

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Cholera Vaccines market report include:
  • EuBiologics Co., Ltd.
  • Shantha Biotechnics Private Limited
  • Incepta Vaccine Ltd.
  • Sanofi Pasteur S.A.
  • Valneva SE
  • Emergent BioSolutions Inc.
  • Bharat Biotech International Limited

Table Information

Report AttributeDetails
No. of Pages188
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 329.81 Million
Forecasted Market Value ( USD ) by 2030 $ 470.18 Million
Compound Annual Growth Rate7.3%
Regions CoveredGlobal
No. of Companies Mentioned8

Related Topics

Related Reports

Cholera Vaccines Market Size, Share & Analysis Report By Type (Whole cell V. Cholerae O1 Recombinant With B-Subunit), By Product (Vaxchora, Dukoral), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Cholera Vaccines Market Size, Share & Analysis Report By Type (Whole cell V. Cholerae O1 Recombinant With B-Subunit), By Product (Vaxchora, Dukoral), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Cholera Vaccines Market Report by Vaccine Type, Product, End User, and Region 2025-2033 - Product Image

Cholera Vaccines Market Report by Vaccine Type, Product, End User, and Region 2025-2033

  • Report
  • 135 Pages
  • Global
From
Cholera Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Cholera Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From
Cholera Vaccines - Global Strategic Business Report - Product Image

Cholera Vaccines - Global Strategic Business Report

  • Report
  • 367 Pages
  • Global
From
Cholera Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Cholera Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From

About the Cholera Vaccine Market

The Cholera Vaccine market is a subset of the larger Vaccines market. Cholera is an acute diarrheal infection caused by the bacterium Vibrio cholerae. Vaccines are the most effective way to prevent cholera, and the World Health Organization recommends that all people at risk of cholera should be vaccinated. The Cholera Vaccine market is composed of a variety of products, including oral and injectable vaccines. Oral vaccines are typically administered in two doses, while injectable vaccines are administered in a single dose. The Cholera Vaccine market is highly competitive, with a number of companies offering products. These include Sanofi Pasteur, GlaxoSmithKline, Merck, Pfizer, and Emergent BioSolutions. Each company offers a range of products, including both oral and injectable vaccines. Additionally, some companies have developed combination vaccines that protect against multiple diseases, including cholera. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.